Higher Donor Age and Severe Microvascular Inflammation Are Risk Factors for Chronic Rejection After Treatment of Active Antibody-Mediated Rejection

Higher Donor Age and Severe Microvascular Inflammation Are Risk Factors for Chronic Rejection After Treatment of Active Antibody-Mediated Rejection

Recent developments in intensive desensitization protocols have enabled kidney transplantation in human leukocyte antigen (HLA)-sensitized recipients. However, cases of active antibody-mediated rejection (AABMR), when they occur, are difficult to manage, graft failure being the worst-case scenario....

Full description

Bibliographic Details
Main Authors: Taro Banno, Toshihito Hirai, Rikako Oki, Takafumi Yagisawa, Kohei Unagami, Taichi Kanzawa, Kazuya Omoto, Tomokazu Shimizu, Hideki Ishida, Toshio Takagi
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Transplant International
Subjects:
antibody-mediated rejection
Banff classification
graft survival
kidney transplantation
treatment outcomes
Online Access:https://www.frontierspartnerships.org/articles/10.3389/ti.2024.11960/full

Similar Items

Similar Items